Tag: Steve Wang
Firms advise on Insilico Medicine’s HKD2.28bn HKEX IPO
AI drug discovery firm Insilico Medicine listed on the HKEX main board on 30 December 2025
Five law firms assist XDC in raising HKD3.68bn from spin-off
Fangda Partners, Wilson Sonsini, Maples Group, Davis Polk and Jingtian & Gongcheng advised Chinese medical research group WuXi XDC on a spin-off listing
Five law firms advise on largest chapter 18A listing in Hong Kong
Five law firms advised on Chinese biotechnology company Laekna’s HKD791 million chapter 18A offering, which is the largest such IPO to date this year














